or Try an Advanced Search...

    Technical Analysis for AUGX - Augmedix, Inc.

    Grade Last Price % Change Price Change
    D 2.35 0.00% 0.00
    AUGX closed unchanged on Tuesday, October 1, 2024, on 5 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Down Up Up
    Historical AUGX trend table...
    Date Alert Name Type % Chg
    Expansion Breakout Bullish Swing Setup 0.00%
    Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Overbought Stochastic Strength 0.00%
    Gapped Down Weakness 0.00%
    Expansion Breakout Bullish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Weak + Overbought Other 0.00%
    BB Squeeze + Upper Band Touch Range Contraction 0.00%
    Above Upper BB Strength 0.00%
    Older End-of-Day Signals for AUGX ...

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    AUGX Chart by TradingView
    Basic chart:

    Profile

    Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. It offers software that is compatible with off-the-shelf, mobile client devices, which enables clinicians to communicate with remotely located documentation specialists (RDSs). The company's services include Augmedix Live, a real time service, in which RDSs provide medical documentation and live clinical support services; and Augmedix Notes, a non-real time product where RDSs offer medical documentation based upon recorded visits. Its clients include health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Health Information Services
    Keywords: Health Informatics Health Systems Information Science Technical Communication Clinical Support Services

    Is AUGX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 2 Commure Completes Merger with Augmedix
    Aug 12 Augmedix, Inc. (AUGX) Reports Q2 Loss, Lags Revenue Estimates
    Aug 12 Augmedix GAAP EPS of -$0.16 misses by $0.03, revenue of $13.66M beats by $0.02M
    Aug 12 Augmedix Delivers 27% Revenue Growth for Second Quarter of 2024
    Aug 6 Augmedix to Announce Second Quarter 2024 Financial Results on August 12, 2024
    Jul 22 Commure signs agreement to acquire Augmedix in $139m deal
    Jul 19 AI-Focused Healthcare Documentation Provider Augmedix Goes Private In $139M Deal
    Jul 19 Augmedix to be acquired by Commure in transaction valuing the former at ~$139M
    Jul 19 Augmedix to Join Forces with Commure
    Jul 15 Why Is Augmedix, Inc. (AUGX) the Best Penny Stock to Buy Under $1?
    See more AUGX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.25
    52 Week Low 0.73
    Average Volume 437,723
    200-Day Moving Average 3.01
    50-Day Moving Average 2.30
    20-Day Moving Average 2.33
    10-Day Moving Average 2.34
    Average True Range 0.02
    RSI (14) 74.03
    ADX 66.35
    +DI 30.03
    -DI 4.85
    Chandelier Exit (Long, 3 ATRs) 2.30
    Chandelier Exit (Short, 3 ATRs) 2.34
    Upper Bollinger Bands 2.35
    Lower Bollinger Band 2.31
    Percent B (%b) 0.94
    BandWidth 1.99
    MACD Line 0.04
    MACD Signal Line 0.05
    MACD Histogram -0.0111
    Fundamentals Value
    Market Cap 114.1 Million
    Num Shares 48.6 Million
    EPS -0.50
    Price-to-Earnings (P/E) Ratio -4.70
    Price-to-Sales 5.33
    Price-to-Book 285.77
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.37
    Resistance 3 (R3) 2.36 2.36 2.36
    Resistance 2 (R2) 2.36 2.35 2.36 2.36
    Resistance 1 (R1) 2.35 2.35 2.36 2.36 2.36
    Pivot Point 2.35 2.35 2.35 2.35 2.35
    Support 1 (S1) 2.34 2.34 2.35 2.35 2.34
    Support 2 (S2) 2.34 2.34 2.34 2.34
    Support 3 (S3) 2.33 2.34 2.34
    Support 4 (S4) 2.34